A double-blind, placebo-controlled, randomized trial of montelukast for acute bronchiolitis

Pediatrics

Volumn 122, Issue 6, 2008, Pages

  Amirav, Israel ^a,b   Luder, Anthony S ^a,b   Kruger, Natalie ^a   Borovitch, Yael ^c   Babai, Ilan ^c,d   Miron, Dan ^a,b   Zuker, Miriam ^a   Tal, Gay ^e   Mandelberg, Avigdor ^c,d  

^a ZIV MEDICAL CENTER   (Israel)

^b TECHNION ISRAEL INSTITUTE OF TECHNOLOGY   (Israel)

^c WOLFSON MEDICAL CENTER   (Israel)

^d TEL AVIV UNIVERSITY   (Israel)

^e WEIZMANN INSTITUTE OF SCIENCE   (Israel)

Author keywords

Bronchiolitis; Controlled clinical trial; Montelukast; Pediatrics; Respiratory syncytial virus

Indexed keywords

GAMMA INTERFERON; INTERLEUKIN 10; INTERLEUKIN 12P70; INTERLEUKIN 1BETA; INTERLEUKIN 2; INTERLEUKIN 4; INTERLEUKIN 5; INTERLEUKIN 6; INTERLEUKIN 8; MONTELUKAST; PEPTIDOLEUKOTRIENE; PLACEBO; TUMOR NECROSIS FACTOR ALPHA; ACETIC ACID DERIVATIVE; AUTACOID; CYTOKINE; LEUKOTRIENE RECEPTOR BLOCKING AGENT; QUINOLINE DERIVATIVE;

ACUTE DISEASE; ARTICLE; BRONCHIOLITIS; CHILD; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CONVALESCENCE; CORRELATION ANALYSIS; CYTOKINE PRODUCTION; DISEASE COURSE; DISEASE SEVERITY; DOUBLE BLIND PROCEDURE; DRUG EFFECT; DRUG FORMULATION; DRUG MECHANISM; EVENING DOSAGE; FEMALE; HOSPITALIZATION; HUMAN; INFANT; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; NOSE MUCUS; PRESCHOOL CHILD; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; TH1 CELL; TH2 CELL; BLOOD; CROSSOVER PROCEDURE; DOSE RESPONSE; DRUG ADMINISTRATION; DRUG DELIVERY SYSTEM; FOLLOW UP; METABOLISM; NEWBORN; NONPARAMETRIC TEST; PROBABILITY; PROSPECTIVE STUDY; TREATMENT OUTCOME;

ACETATES; ACUTE DISEASE; BRONCHIOLITIS; CROSS-OVER STUDIES; CYTOKINES; DOSE-RESPONSE RELATIONSHIP, DRUG; DOUBLE-BLIND METHOD; DRUG ADMINISTRATION SCHEDULE; DRUG DELIVERY SYSTEMS; FEMALE; FOLLOW-UP STUDIES; HOSPITALIZATION; HUMANS; INFANT; INFANT, NEWBORN; INFLAMMATION MEDIATORS; LEUKOTRIENE ANTAGONISTS; MALE; PROBABILITY; PROSPECTIVE STUDIES; QUINOLINES; SEVERITY OF ILLNESS INDEX; STATISTICS, NONPARAMETRIC; TREATMENT OUTCOME;

EID: 58249087373     PISSN: 00314005     EISSN: 10984275     Source Type: Journal    
DOI: 10.1542/peds.2008-1744     Document Type: Article

References (34)

1. Shay DK, Holman RC, Roosevelt GE, Clarke MJ, Anderson LJ. Bronchiolitis-associated mortality and estimates of respiratory syncytial virus-associated deaths among US children, 1979-1997. J Infect Dis. 2001;183(1):16-22
2. Sigurs N. Epidemiologic and clinical evidence of a respiratory syncytial virus-reactive airway disease link. Am J Respir Crit Care Med. 2001;163(3 pt 2):S2-S6
3. Sigurs N, Bjarnason R, Sigurbergsson F, Kjellman B. Respiratory syncytial virus bronchiolitis in infancy is an important risk factor for asthma and allergy at age 7. Am J Respir Crit Care Med. 2000;161(5):1501-1507
4. Smyth RL, Openshaw PJ. Bronchiolitis. Lancet. 2006; 368(9532)312-322
5. Stein RT, Sherrill D, Morgan WJ, et al. Respiratory syncytial virus in early life and risk of wheeze and allergy by age 13 years. Lancet. 1999;354(9178):541-545
6. Kellner JD, Ohlsson A, Gadomski AM, Wang EE. Bronchodilators for bronchiolitis. Cochrane Database Syst Rev. 2000;(2):CD001266
7. Corneli HM, Zorc JJ, Majahan P, et al. A multicenter, randomized, controlled trial of dexamethasone for bronchiolitis. N Engl JMed. 2007;357(4):331-339
8. Klassen TP, Sutcliffe T, Watters LK, Wells GA, Allen UD, Li MM. Dexamethasone in salbutamol-treated inpatients with acute bronchiolitis: a randomized, controlled trial. J Pediatr. 1997;130(2):191-196
9. Bulow SM, Nir M, Levin E, et al. Prednisolone treatment of respiratory syncytial virus infection: a randomized controlled trial of 147 infants. Pediatrics. 1999;104(6). Available at: www.pediatrics.org/cgi/content/ full/104/6/e77
10. Richter H, Seddon P. Early nebulized budesonide in the treatment of bronchiolitis and the prevention of postbronchiolitic wheezing. J Pediatr. 1998;132(5):849-853
11. Fox GF, Everard ML, Marsh MJ, Milner AD. Randomized controlled trial of budesonide for the prevention of post-bronchiolitis wheezing. Arch Dis Child. 1999;80(4):343-347
12. Mandelberg A, Tal G, Witzling M, et al. Nebulized 3% hyper-tonic saline treatment in hospitalized infants with viral bron-chiolitis. Chest. 2003;123(2):481-487
13. Gern JE, Busse WW. The role of viral infections in the natural history of asthma. J Allergy Clin Immunol. 2000;106(2):201-212
14. Volovitz B, Welliver RC, De Castro G, Krystofik DA, Ogra PL. The release of leukotrienes in the respiratory tract during infection with respiratory syncytial virus: role in obstructive airway disease. Pediatr Res. 1988;24(4):504-507
15. Volovitz B, Faden H, Ogra PL. Release of leukotriene C4 in respiratory tract during acute viral infection. J Pediatr. 1988;112(2):218-222
16. van Schaik SM, Tristram DA, Nagpal IS, Hintz KM, Welliver RC II, Welliver RC. Increased production of IFN-y and cysteinyl leukotrienes in virus-induced wheezing. J Allergy Clin Immunol. 1999;103(4):630-636
17. Da Dalt L, Callegaro S, Carraro S, Andreola B, Corradi M, Baraldi E. Nasal lavage leukotrienes in infants with RSVB. Pediatr Allergy Immunol. 2007;18(2):100-104
18. Dimova-Yaneva D, Russell D, Main M, Brooker RJ, Helms PJ. Eosinophil activation and cysteinyl leukotriene production in infants with respiratory syncytial virus bronchiolitis. Clin Exp Allergy. 2004;34(4):555-558
19. Bisgaard H. Leukotriene modifiers in pediatric asthma management. Pediatrics. 2001;107(2):381-390
20. Legg JP, Hussain IR, Warner JA, Johnston SL, Warner JO. Type 1 and type 2 cytokine imbalance in acute respiratory syncytial virus bronchiolitis. Am J Respir Crit Care Med. 2003;168(6):633-639
21. Ciprandi G, Frati F, Marcucci F, Sensi L, Tosca MA, Milanese M, Ricca V. Nasal cytokine modulation by montelukast in allergic children: a pilot study. Allerg Immunol (Paris). 2003; 35(8):295-299
22. Bisgaard H; Study Group on Montelukast and Respiratory Syncytial Virus. A randomized trial of montelukast in respiratory syncytial virus postbronchiolitis. Am J Respir Crit Care Med. 2003;167(3):379-383
23. Harmanci K, Bakirtas A, Turktas I, Degim T. Oral montelukast treatment of preschool-aged children with acute asthma. Ann Allergy Asthma Immunol. 2006;96(5):731-735
24. Robertson CF, Price D, Henry R, et al. Short-course montelukast for intermittent asthma in children: a randomized controlled trial. Am J Respir Crit Care Med. 2007;175(4):323-329
25. Wainwright C, Altamirano L, Cheney M, et al. A multicenter, randomized, double-blind, controlled trial of nebulized epi-nephrine in infants with acute bronchiolitis. N Engl J Med. 2003;349(1):27-35
26. Wang EE, Milner RA, Navas L, Maj H. Observer agreement for respiratory signs and oximetry in infants hospitalized with lower respiratory infections. Am Rev Respir Dis. 1992;145(1):106-109
27. Bisgaard H, Zielen S, Garcia-Garcia ML, et al. Montelukast reduces asthma exacerbations in 2-to 5-year-old children with intermittent asthma. Am J Respir Crit Care Med. 2005;171(4): 315-322
28. Straub DA, Moeller A, Minocchieri S, et al. The effect of montelukast on lung function and exhaled nitric oxide in infants with early childhood asthma. Eur Respir J. 2005;25(2):289-294
29. Knorr B, Maganti L, Ramakrishnan R, Tozzi CA, Migoya E, Kearns G. Pharmacokinetics and safety of montelukast in children aged 3 to 6 months. J Clin Pharmacol. 2006;46(6):620-627
30. Ji JZ, Chen ZG, Chen YF, Chen FH, Chen H, Deng L. Effect of leukotriene receptor antagonist on the levels of Th1 and Th2 cytokines in sera of infants with respiratory syncytial virus pneumonia. Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi. 2007;21(2):132-134
31. Bennett BL, Garofalo RP, Cron SG, et al. Immunopathogenesis of respiratory syncytial virus bronchiolitis. J Infect Dis. 2007; 195(10):1532-1540
32. Frischer T, Baraldi E. Upper airway sampling. Am J Respir Crit Care Med. 2000;162(2 pt 2):S28-S30
33. Everard ML, Swarbrick A, Wrightham M, et al. Analysis of cells obtained by bronchial lavage of infants with respiratory syn-cytial virus infection. Arch Dis Child. 1994;71(5):428-432
34. Joshi P, Kakakios A, Jayasekera J, Isaacs D. A comparison of IL-2 levels in nasopharyngeal and endotracheal aspirates of babies with respiratory syncytial viral bronchiolitis. J Allergy Clin Immunol. 1998;102(4pt 1):618-620